Contravisory Investment Management’s Unilever UL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.3K Sell
554
-1,065
-66% -$61.6K 0.01% 280
2026
Q1
$92.2K Sell
1,619
-1,104
-41% -$74K 0.02% 234
2025
Q4
$178K Sell
2,723
-9
-0.3% -$605 0.04% 231
2025
Q3
$182K Sell
2,732
-4,188
-61% -$289K 0.04% 248
2025
Q2
$476K Buy
6,920
+1,004
+17% +$70.4K 0.09% 165
2025
Q1
$396K Buy
5,916
+2,833
+92% +$183K 0.08% 183
2024
Q4
$197K Buy
+3,083
New +$208K 0.04% 224
2023
Q4
Sell
-2,696
Closed -$150K 422
2023
Q3
$150K Buy
2,696
+157
+6% +$9.07K 0.04% 216
2023
Q2
$149K Buy
2,539
+1,102
+77% +$65.4K 0.04% 211
2023
Q1
$84K Buy
1,437
+165
+13% +$9.37K 0.02% 226
2022
Q4
$72.1K Buy
+1,272
New +$68.1K 0.02% 234
2016
Q4
Sell
-214
Closed -$11K 326
2016
Q3
$11K Buy
214
+17
+9% +$898 ﹤0.01% 199
2016
Q2
$11K Buy
+197
New +$10.1K ﹤0.01% 123

Other funds holding UL

Contravisory Investment Management's UL Position: Q2 2026 in Review

Contravisory Investment Management reduced its Unilever (UL) stake by 66% in Q2 2026, selling an estimated $61.6K and leaving 554 shares worth $33.3K. The position accounts for 0.01% of the portfolio, ranked #280.

Contravisory Investment Management first reported a position in UL in Q2 2016 and has held it in 13 quarters since. The position peaked at $476K in Q2 2025. 1,187 funds tracked by Wall St. Rank hold UL as of Q2 2026.

  • Contravisory Investment Management held 554 shares of Unilever worth $33.3K as of Q2 2026.
  • Contravisory Investment Management sold 1,065 Unilever shares in Q2 2026, an estimated $61.6K.
  • Unilever made up 0.01% of Contravisory Investment Management's portfolio in Q2 2026, its #280 holding.
  • Contravisory Investment Management first reported a position in Unilever in Q2 2016 and has held it in 13 quarters since.
  • Contravisory Investment Management's Unilever position peaked at $476K in Q2 2025.
  • 1,187 funds tracked by Wall St. Rank held Unilever as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.